Criteria for the classification of early systemic sclerosis.

EC LeRoy, TA Medsger - The Journal of rheumatology, 2001 - jrheum.org
EC LeRoy, Department of Microbiology and Immunology, Medical University of South
Carolina, 173 Ashley Avenue, PO Box 250504, Charleston, SC 29425. E-mail: leroyc@musc.edu …

Raynaud's phenomenon: a proposal for classification.

EC LeRoy, TA Medsger Jr - Clinical and experimental rheumatology, 1992 - europepmc.org
Major confusion exists with regard to the definition of patients with Raynaud's phenomenon;
defining the patient and the phenomenon are reasonably straightforward, but variations in …

Systemic sclerosis: a vascular perspective

EC LeRoy - Rheumatic disease clinics of North America, 1996 - Elsevier
… or along with EC perturbation is unknown; certainly EC changes, at … to EC abnormalities is
unknown; certainly subcutaneous inflammation (eg photoinjury) can occur without residual EC

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

EC LeRoy, CM Black, R Fleischmajer… - J …, 1988 - api.taylorfrancis.com
A subclassification of SSc patients is proposed by a group of experienced investigators. The
subsets are defined by skin involvement with limited cutaneous SSc (lcSSc) patients having …

Increased collagen synthesis by scleroderma skin fibroblasts in vitro a possible defect in the regulation or activation of the scleroderma fibroblast

EC LeRoy - The Journal of clinical investigation, 1974 - Am Soc Clin Investig
Cultures of dividing skin fibroblasts from normal and sclerodermatous human skin have
permitted estimations of soluble collagen concentration, net collagen accumulation, cell-…

Natural history of asymptomatic left ventricular systolic dysfunction in the community

TJ Wang, JC Evans, EJ Benjamin, D Levy, EC LeRoy… - Circulation, 2003 - Am Heart Assoc
Background— Information is limited regarding the rates of progression to congestive heart
failure (CHF) and death in individuals with asymptomatic left ventricular systolic dysfunction (…

Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders

HR Maricq, EC LeRoy, WA D'angelo… - Arthritis & …, 1980 - Wiley Online Library
… Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC: … Maricq HR, LeRoy
EC: Patterns of finger capillary ab… Maricq HR, Spencer-Green G, LeRoy EC: Skin capillary …

A disease severity scale for systemic sclerosis: development and testing.

…, MI Jayson, SA Jimenez, T Krieg, EC Leroy… - The Journal of …, 1999 - europepmc.org
Objective To develop and test a severity scale for individual organ involvements in systemic
sclerosis (SSc, scleroderma). Methods An international study group completed the following …

The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical …

…, WJ CASARELLA, SC SOMMERS, EC LeROY - Medicine, 1974 - journals.lww.com
Scleroderma (progressive systemic sclerosis) is a disease of unknown etiology characterized
by widespread alterations of connective tissue and by vascular lesions in many organs (S1)…

Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease.

…, FE Harper, MM Khan, EM Tan, EC LeRoy - Clinical and …, 1983 - europepmc.org
In vivo capillary examination was performed on 80 patients included in a prospective study
of Raynaud phenomenon (RP): 40 RP only (RPO), 20 undifferentiated connective tissue …